Lipodystrophy syndrome is a clinically variable and causally heterogeneous disorder 1, 2 .
A 33-year-old Japanese woman presented with 'sporadic' congenital partial lipodystrophy (CPLD) associated with mandibuloacral dysplasia (MAD) and an unusual fat maldistribution (Figure 1a d). She had many unique features, such as growth retardation without cognitive dysfunction, bilateral sensorineural deafness and alopecia (Figure 1f,g ), which coexisted with various progeroid features distinct from those previously described in classical CPLD and/or MAD-A/B types [1] [2] [3] , thus suggesting a novel subtype of CPLD or a new causative syndrome.
She was born at full-term gestation. Her parents first noted fat loss in her limbs during infancy, and she subsequently developed poor overall growth (Figure 1f ). Deafness was detected at prepuberty. At 10 years-of-age, an extensive endocrinological investigation including growth hormones, insulin-like growth factor-1 levels, thyroid and adrenal functions, and head computed tomography showed no abnormalities. At 14 years-ofage, she was admitted for leg muscle cramps on several occasions. Subcutaneous fat loss was noted predominantly in the face and extremities. An oral glucose tolerance test (1.7-g glucose/kg) showed normal glucose tolerance (Japan hands and soles of her feet was noted (Figure 1a-c) . Abdominal computed tomography and whole body magnetic resonance images confirmed visceral fat accumulation (visceral fat area/subcutaneous fat area = 217.1/13.3 cm 2 at the navel level) with mandibular hypoplasia without clavicular hypoplasia (Figure 1d,  e) . She showed hirsutism, acanthosis nigricans, alopecia areata (Figure 1b,g ) and dysmenorrhea (due to polycystic ovary syndrome based on the low sex hormone-binding globulin, normal free testosterone, elevated luteinizing hormone/follicle-stimulating hormone ratio and a polycystic pattern on magnetic resonance imaging [T1, T2WI/fat suppression imaging]). Low plasma leptin/ adiponectin levels were observed (3.6 ng/ mL and 2.4 lg/mL, respectively). An oral glucose tolerance test revealed a diabetic pattern (fasting plasma glucose 103, 2 h 230 mg/dL) with hyperinsulinemia (fasting immunoreactive insulin 23.8, 2 h 226.9 lU/mL), and severe insulin resistance was confirmed by the glucose clamp technique (glucose infusion rate 4.32 mg/ kg/min at an infusion rate of 1.5 mU/kg/ min; healthy control 10.9 -4.2). A sequence analysis was carried out to establish genetic causes; however, no key mutations for CPLD or MAD (LMNA gene encoding lamin A and C, peroxisome proliferator-activated receptor gamma, perilipin, cell death-inducing fiffa-like effector C, zinc metalloprotein STE24 and PTRF gene encoding cavin-1) 1,2 were identified. Potential causative factors included the regional differences in fat deposition as a result of the variable expression of unknown genetic mutations, and the severity of insulin resistance, potentially leading to various metabolic derangements. Recently, seven atypical MAD cases with lipodistrophy were reported by Shastry et al. 4 ; two female patients shared some phenotypic similarities with our case, including deafness, a short stature and mandible hypoplasia of unknown genetic origin. The other five patients were males with hypogonadism. This is the first such report in Asia, including Japan. The unique clinical manifestations of this case are herein reported because of its rarity.
